- Pokroky ve vývoji nových antituberkulotikPublikace bez příslušnosti k fakultě
- Pokroky ve vývoji antituberkulotikPublikace bez příslušnosti k fakultě
- New series of isoniazid hydrazones linked with electron-withdrawing substituents2011 | Farmaceutická fakulta v Hradci Králové
- New fluorine-containing hydrazones active against MDR-tuberculosis2011 | Farmaceutická fakulta v Hradci Králové
- Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis2018 | Farmaceutická fakulta v Hradci Králové
- Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade2015 | Farmaceutická fakulta v Hradci Králové
- New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action2018 | Farmaceutická fakulta v Hradci Králové
- N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-the Synthesis and Biological Evaluation of Enantiomers2020 | Farmaceutická fakulta v Hradci Králové
- Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids2017 | Farmaceutická fakulta v Hradci Králové
- Design and synthesis of 2-(2-isonicotinoylhydrazineylidene) propanamides as InhA inhibitors with high antitubercular activity2021 | Farmaceutická fakulta v Hradci Králové
- Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid2021 | Farmaceutická fakulta v Hradci Králové